# A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)

> **NCT01112995** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 49 (estimated)

## Conditions studied

- Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus rhamnosus
- **DIETARY_SUPPLEMENT:** Sugar pill (placebo)

## Key facts

- **NCT ID:** NCT01112995
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-03
- **Final completion:** 2012-03
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2015-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01112995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01112995, "A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01112995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*